Glycorex Transplantation AB (publ) - Laporan Laba Rugi (TTM)

Glycorex Transplantation AB (publ)
SE ˙ NGM
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Glycorex Transplantation AB (publ) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 30 29 25 30 30 29 31 34 35 37 37 35 32 30 31 31 32 35 37 38
Change (%) -4.43 -11.76 18.43 -2.04 -2.28 8.58 9.96 0.55 7.83 -1.32 -5.32 -7.17 -6.10 3.21 -0.66 3.51 8.80 4.56 2.48
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 4 4 3 3 3 4 5 7 6 6 4 2 4 4 5 5 6 7 7 7
Change (%) -6.61 -15.76 -17.61 8.52 30.70 32.84 41.06 -14.86 -7.19 -37.99 -50.11 100.39 -0.77 43.17 6.80 2.84 22.68 1.34 -5.44
% of Revenue 14.21 13.89 13.26 9.22 10.22 13.66 16.72 21.45 18.16 15.63 9.82 5.18 11.17 11.81 16.38 17.61 17.49 19.72 19.12 17.64
Gross Operating Profit 26 25 22 27 27 25 26 27 28 32 33 33 29 27 26 26 27 28 30 31
Change (%) -4.07 -11.12 23.94 -3.11 -6.03 4.74 3.71 4.75 11.16 5.47 -0.44 -13.04 -6.77 -2.14 -2.12 3.65 5.86 5.36 4.34
% of Revenue 85.79 86.11 86.74 90.78 89.78 86.34 83.28 78.55 81.84 84.37 90.18 94.82 88.83 88.19 83.62 82.39 82.51 80.28 80.88 82.36
SG&A 25 26 28 29 29 29 29 29 31 32 34 36 36 37 35 33 31 29 29 29
Change (%) 4.39 7.73 6.14 -0.34 -0.19 -0.58 0.83 5.59 4.42 6.19 3.62 0.88 3.01 -4.64 -6.85 -5.30 -5.58 -1.39 0.92
% of Revenue 81.50 89.01 108.69 97.41 99.09 101.21 92.67 84.98 89.24 86.42 92.99 101.77 110.59 121.32 112.09 105.11 96.16 83.45 78.70 77.51
R&D
Change (%)
% of Revenue
OpEx 35 36 38 39 39 41 42 45 45 46 45 46 48 48 48 47 45 46 45 45
Change (%) 4.07 5.87 1.23 2.26 3.22 3.00 6.18 1.22 1.54 -0.54 0.99 4.24 1.06 0.15 -3.83 -3.32 1.13 -0.60 -0.18
% of Revenue 114.45 124.62 149.52 127.80 133.41 140.90 133.67 129.07 129.93 122.35 123.31 131.53 147.70 158.96 154.24 149.32 139.47 129.63 123.23 120.04
Operating Income -4 -7 -13 -8 -10 -12 -11 -10 -10 -8 -9 -11 -15 -18 -17 -15 -13 -10 -9 -8
Change (%) 62.86 77.48 -33.52 17.72 19.66 -10.63 -5.05 3.51 -19.46 2.92 28.05 40.43 16.07 -5.05 -9.67 -17.16 -18.31 -18.04 -11.61
% of Revenue -14.45 -24.62 -49.52 -27.80 -33.41 -40.90 -33.67 -29.07 -29.93 -22.35 -23.31 -31.53 -47.70 -58.96 -54.24 -49.32 -39.47 -29.63 -23.23 -20.04
Interest Expense -0 -0 -1 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -1 -1 -1 -1 -1
Change (%) 7.62 69.62 -33.39 1.57 -30.85 -1.86 -35.98 -15.98 73.94 -5.67 16.31 -9.96 18.44 28.03 36.76 30.83 -12.69 3.46 -14.38
% of Revenue -1.04 -1.17 -2.26 -1.27 -1.32 -0.93 -0.84 -0.49 -0.41 -0.66 -0.63 -0.78 -0.75 -0.95 -1.18 -1.62 -2.05 -1.64 -1.63 -1.36
Net Income -5 -8 -14 -9 -11 -12 -11 -10 -11 -9 -9 -11 -16 -30 -30 -28 -26 -11 -9 -8
Change (%) 67.57 70.63 -32.47 16.00 13.93 -10.09 -5.44 3.22 -20.18 2.68 25.26 42.18 93.61 -2.72 -5.79 -8.23 -57.16 -17.00 -11.86
% of Revenue -15.88 -27.84 -53.85 -30.70 -36.36 -42.39 -35.10 -30.18 -30.99 -22.94 -23.87 -31.57 -48.36 -99.72 -93.99 -89.14 -79.03 -31.12 -24.70 -21.25

Source: Capital IQ

Other Listings
DE:O33
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista